Infectious syndromes in solid tumor therapy James A Talcott and John R Wingard

Infection is a major cause of morbidity and mortality in cancer patients receiving myelosuppressive chemotherapy.1,2 The likelihood of infection is influenced by the disease, its physical extent, and the effects of the treatment that the patient is undergoing.